Mycronic AB (publ)
MICLF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $2 | $2 | $2 |
| % Growth | -91.2% | -3.5% | 4% | – |
| Cost of Goods Sold | $0 | $1 | $1 | $1 |
| Gross Profit | $0 | $1 | $1 | $1 |
| % Margin | 46.3% | 53.4% | 61.2% | 48.8% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | -$0 |
| Operating Expenses | $0 | $1 | $1 | $0 |
| Operating Income | $0 | $1 | $1 | $1 |
| % Margin | 20% | 27.8% | 37.7% | 25.5% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | $0 |
| Pre-Tax Income | $0 | $1 | $1 | $1 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $0 | $0 | $1 | $0 |
| % Margin | 12.7% | 21.6% | 28.9% | 22.3% |
| EPS | 0.12 | 2.28 | 3.18 | 2.36 |
| % Growth | -94.7% | -28.3% | 34.7% | – |
| EPS Diluted | 0.12 | 2.28 | 3.18 | 2.36 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | $1 | $1 | $1 |
| % Margin | 20.2% | 27.8% | 37.7% | 26% |